dihexa pnb-0408 c-met hgfr activator Activated HGF-c-Met Axis in Head and Neck Cancer Targeting HGF/c-MET signaling to regulate
Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion PMC dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4 Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3



